Zobrazeno 1 - 10
of 211
pro vyhledávání: '"Marco A. De Velasco"'
Autor:
Makoto Matsushita, Kazutoshi Fujita, Koji Hatano, Marco A. De Velasco, Akira Tsujimura, Hirotsugu Uemura, Norio Nonomura
Publikováno v:
The World Journal of Men's Health, Vol 41, Iss 4, Pp 759-768 (2023)
The human gut microbiota changes under the influence of environmental and genetic factors, affecting human health. Extensive studies have revealed that the gut microbiome is closely associated with many non-intestinal diseases. Among these, the inf
Externí odkaz:
https://doaj.org/article/6090f0510ca742ad94c7af247d4dd23e
Autor:
Makoto Matsushita, Kazutoshi Fujita, Koji Hatano, Marco A. De Velasco, Hirotsugu Uemura, Norio Nonomura
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Prostate cancer (PCa) is the most common malignancy in men worldwide, thus developing effective prevention strategies remain a critical challenge. Insulin-like growth factor 1 (IGF-1) is produced mainly in the liver by growth hormone signaling and is
Externí odkaz:
https://doaj.org/article/ec9bb18476d54be4ac66f93c67890c7c
Autor:
Kazuko Sakai, Toshiharu Sakurai, Marco A. De Velasco, Tomoyuki Nagai, Takaaki Chikugo, Kazuomi Ueshima, Yurie Kura, Takayuki Takahama, Hidetoshi Hayashi, Kazuhiko Nakagawa, Masatoshi Kudo, Kazuto Nishio
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Immune checkpoint inhibitors (ICIs) have become the standard of care for several cancers. However, ICI therapy has also been associated with various immune-related adverse events (irAEs). Clinical manifestations of immune-related colitis resemble tho
Externí odkaz:
https://doaj.org/article/6e88ea98895e4ac398d97856814274aa
Autor:
Masato Chiba, Yosuke Togashi, Eri Bannno, Yoshihisa Kobayashi, Yu Nakamura, Hidetoshi Hayashi, Masato Terashima, Marco A. De Velasco, Kazuko Sakai, Yoshihiko Fujita, Tetsuya Mitsudomi, Kazuto Nishio
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background Non-small cell lung cancer (NSCLC) harboring common epidermal growth factor receptor (EGFR) gene mutations (exon 19 deletion or exon 21 L858R) respond to EGFR tyrosine kinase inhibitors (EGFR-TKIs). The secondary T790 M mutation i
Externí odkaz:
https://doaj.org/article/05b17bf231454e9ea7e937d72cd8a9cd
Autor:
Marco A. De Velasco, Hirotsugu Uemura
Publikováno v:
Advances in Urology, Vol 2012 (2012)
Knowledge gained from the identification of genetic and epigenetic alterations that contribute to the progression of prostate cancer in humans is now being implemented in the development of functionally relevant translational models. GEM (genetically
Externí odkaz:
https://doaj.org/article/1d3b331ef1714ab18737b402b460e3b0
Autor:
Toshiharu Sakurai, Marco A De Velasco, Kazuko Sakai, Tomoyuki Nagai, Hiroki Nishiyama, Kentaro Hashimoto, Hirotsugu Uemura, Hisato Kawakami, Kazuhiko Nakagawa, Hiroyuki Ogata, Kazuto Nishio, Masatoshi Kudo
Publikováno v:
Molecular Oncology, Vol 16, Iss 7, Pp 1493-1507 (2022)
Immune checkpoint inhibitors (ICIs) are widely used to treat various malignancies. Although the gut microbiome is known to influence the efficacy of ICIs on epithelial tumors, the functional interactions between gut taxa and colonic mucosa remain poo
Externí odkaz:
https://doaj.org/article/d953bfb730bd47ca942694545bf5a7ad
Autor:
Kazuto Nishio, Suguru Hamada, Kikuo Nutahara, Takatsugu Okegawa, Yoshihiko Fujita, Kazuko Sakai, Marco A. de Velasco, Hidetoshi Hayashi, Masato Terashima, Eri Banno, Shuta Tomida, Hirokazu Nakahara, Yosuke Togashi, Yu Nakamura
Influence of NRG1, a HER4 ligand, on the HRE4 G1109C mutation. A cellular growth assay using 1% FBS medium and western blotting using serum-free medium were performed. When the transfectant HEK293 cell lines were incubated with serum-free medium, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1174933148c13403092b4ac2b8334f26
https://doi.org/10.1158/1535-7163.22508613
https://doi.org/10.1158/1535-7163.22508613
Autor:
Kazuto Nishio, Kiyotaka Okuno, Yoshifumi Takeyama, Takushi Yasuda, Shuta Tomida, Yoshihiko Fujita, Kazuko Sakai, Marco A. de Velasco, Hidetoshi Hayashi, Masato Terashima, Eri Banno, Yoichi Sakamoto, Takuro Mizukami, Akihiro Kogita, Hiroaki Kato, Yosuke Togashi, Shunsuke Sogabe
The captions of Supplementary Tables 1 and 2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fb492f253bae78d80eac8d6e91ca3ff
https://doi.org/10.1158/1535-7163.22502161.v1
https://doi.org/10.1158/1535-7163.22502161.v1
Autor:
Kazuto Nishio, Suguru Hamada, Kikuo Nutahara, Takatsugu Okegawa, Yoshihiko Fujita, Kazuko Sakai, Marco A. de Velasco, Hidetoshi Hayashi, Masato Terashima, Eri Banno, Shuta Tomida, Hirokazu Nakahara, Yosuke Togashi, Yu Nakamura
50% Inhibitory concentrations (IC50) in esophageal or head-and-neck squamous cell carcinoma (ESCC or HNSCC) cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02de671e1970d802f4614ca95174ae74
https://doi.org/10.1158/1535-7163.22508604
https://doi.org/10.1158/1535-7163.22508604
Autor:
Kazuto Nishio, Kiyotaka Okuno, Yoshifumi Takeyama, Takushi Yasuda, Shuta Tomida, Yoshihiko Fujita, Kazuko Sakai, Marco A. de Velasco, Hidetoshi Hayashi, Masato Terashima, Eri Banno, Yoichi Sakamoto, Takuro Mizukami, Akihiro Kogita, Hiroaki Kato, Yosuke Togashi, Shunsuke Sogabe
Supplementary Table 1: Primers for sequencing and mutagenesis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d6523819075d88fb3618f9abfab8542
https://doi.org/10.1158/1535-7163.22502167.v1
https://doi.org/10.1158/1535-7163.22502167.v1